Resources / References
- World Health Organization (WHO) – Cannabidiol (CBD) Critical Review Report (2018)
- European Industrial Hemp Association (EIHA)
- Cannabis Trades Association UK (CTA UK)
- U.S. Food and Drug Administration (FDA) – Cannabis and Cannabis-Derived Compounds
- National Center for Biotechnology Information (NCBI) / PubMed
- Project CBD (Research-Based Nonprofit)
- The Lancet Psychiatry – Cannabidiol for the treatment of psychosis (2019)
- Journal of Clinical Investigation – Cannabidiol and Anxiety (2019)
- Frontiers in Pharmacology – The Endocannabinoid System (2020)
- Harvard Health Publishing – Cannabidiol (CBD): What we know and what we don’t (2021)
Post a Comment